Platelets in Patients with Premature Coronary Artery Disease Exhibit Upregulation of miRNA340 and miRNA624

Coronary artery disease (CAD) is the leading cause of human morbidity and mortality worldwide, underscoring the need to improve diagnostic strategies. Platelets play a major role, not only in the process of acute thrombosis during plaque rupture, but also in the formation of atherosclerosis itself....

Full description

Saved in:
Bibliographic Details
Published in:PloS one Vol. 6; no. 10; p. e25946
Main Authors: Sondermeijer, Brigitte M., Bakker, Annemieke, Halliani, Amalia, de Ronde, Maurice W. J., Marquart, Arnoud A., Tijsen, Anke J., Mulders, Ties A., Kok, Maayke G. M., Battjes, Suzanne, Maiwald, Steffi, Sivapalaratnam, Suthesh, Trip, Mieke D., Moerland, Perry D., Meijers, Joost C. M., Creemers, Esther E., Pinto-Sietsma, Sara-Joan
Format: Journal Article
Language:English
Published: United States Public Library of Science 13.10.2011
Public Library of Science (PLoS)
Subjects:
ISSN:1932-6203, 1932-6203
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Coronary artery disease (CAD) is the leading cause of human morbidity and mortality worldwide, underscoring the need to improve diagnostic strategies. Platelets play a major role, not only in the process of acute thrombosis during plaque rupture, but also in the formation of atherosclerosis itself. MicroRNAs are endogenous small non-coding RNAs that control gene expression and are expressed in a tissue and disease-specific manner. Therefore they have been proposed to be useful biomarkers. It remains unknown whether differences in miRNA expression levels in platelets can be found between patients with premature CAD and healthy controls. In this case-control study we measured relative expression levels of platelet miRNAs using microarrays from 12 patients with premature CAD and 12 age- and sex-matched healthy controls. Six platelet microRNAs were significantly upregulated (miR340*, miR451, miR454*, miR545:9.1. miR615-5p and miR624*) and one miRNA (miR1280) was significantly downregulated in patients with CAD as compared to healthy controls. To validate these results, we measured the expression levels of these candidate miRNAs by qRT-PCR in platelets of individuals from two independent cohorts; validation cohort I consisted of 40 patients with premature CAD and 40 healthy controls and validation cohort II consisted of 27 patients with artery disease and 40 healthy relatives. MiR340* and miR624* were confirmed to be upregulated in patients with CAD as compared to healthy controls in both validation cohorts. Two miRNAs in platelets are significantly upregulated in patients with CAD as compared to healthy controls. Whether the two identified miRNAs can be used as biomarkers and whether they are cause or consequence of the disease remains to be elucidated in a larger prospective study.
AbstractList Coronary artery disease (CAD) is the leading cause of human morbidity and mortality worldwide, underscoring the need to improve diagnostic strategies. Platelets play a major role, not only in the process of acute thrombosis during plaque rupture, but also in the formation of atherosclerosis itself. MicroRNAs are endogenous small non-coding RNAs that control gene expression and are expressed in a tissue and disease-specific manner. Therefore they have been proposed to be useful biomarkers. It remains unknown whether differences in miRNA expression levels in platelets can be found between patients with premature CAD and healthy controls. In this case-control study we measured relative expression levels of platelet miRNAs using microarrays from 12 patients with premature CAD and 12 age- and sex-matched healthy controls. Six platelet microRNAs were significantly upregulated (miR340*, miR451, miR454*, miR545:9.1. miR615-5p and miR624*) and one miRNA (miR1280) was significantly downregulated in patients with CAD as compared to healthy controls. To validate these results, we measured the expression levels of these candidate miRNAs by qRT-PCR in platelets of individuals from two independent cohorts; validation cohort I consisted of 40 patients with premature CAD and 40 healthy controls and validation cohort II consisted of 27 patients with artery disease and 40 healthy relatives. MiR340* and miR624* were confirmed to be upregulated in patients with CAD as compared to healthy controls in both validation cohorts. Two miRNAs in platelets are significantly upregulated in patients with CAD as compared to healthy controls. Whether the two identified miRNAs can be used as biomarkers and whether they are cause or consequence of the disease remains to be elucidated in a larger prospective study.
Background Coronary artery disease (CAD) is the leading cause of human morbidity and mortality worldwide, underscoring the need to improve diagnostic strategies. Platelets play a major role, not only in the process of acute thrombosis during plaque rupture, but also in the formation of atherosclerosis itself. MicroRNAs are endogenous small non-coding RNAs that control gene expression and are expressed in a tissue and disease-specific manner. Therefore they have been proposed to be useful biomarkers. It remains unknown whether differences in miRNA expression levels in platelets can be found between patients with premature CAD and healthy controls. Methodology/Principal Findings In this case-control study we measured relative expression levels of platelet miRNAs using microarrays from 12 patients with premature CAD and 12 age- and sex-matched healthy controls. Six platelet microRNAs were significantly upregulated (miR340*, miR451, miR454*, miR545:9.1. miR615-5p and miR624*) and one miRNA (miR1280) was significantly downregulated in patients with CAD as compared to healthy controls. To validate these results, we measured the expression levels of these candidate miRNAs by qRT-PCR in platelets of individuals from two independent cohorts; validation cohort I consisted of 40 patients with premature CAD and 40 healthy controls and validation cohort II consisted of 27 patients with artery disease and 40 healthy relatives. MiR340* and miR624* were confirmed to be upregulated in patients with CAD as compared to healthy controls in both validation cohorts. Conclusion/Significance Two miRNAs in platelets are significantly upregulated in patients with CAD as compared to healthy controls. Whether the two identified miRNAs can be used as biomarkers and whether they are cause or consequence of the disease remains to be elucidated in a larger prospective study.
Coronary artery disease (CAD) is the leading cause of human morbidity and mortality worldwide, underscoring the need to improve diagnostic strategies. Platelets play a major role, not only in the process of acute thrombosis during plaque rupture, but also in the formation of atherosclerosis itself. MicroRNAs are endogenous small non-coding RNAs that control gene expression and are expressed in a tissue and disease-specific manner. Therefore they have been proposed to be useful biomarkers. It remains unknown whether differences in miRNA expression levels in platelets can be found between patients with premature CAD and healthy controls.BACKGROUNDCoronary artery disease (CAD) is the leading cause of human morbidity and mortality worldwide, underscoring the need to improve diagnostic strategies. Platelets play a major role, not only in the process of acute thrombosis during plaque rupture, but also in the formation of atherosclerosis itself. MicroRNAs are endogenous small non-coding RNAs that control gene expression and are expressed in a tissue and disease-specific manner. Therefore they have been proposed to be useful biomarkers. It remains unknown whether differences in miRNA expression levels in platelets can be found between patients with premature CAD and healthy controls.In this case-control study we measured relative expression levels of platelet miRNAs using microarrays from 12 patients with premature CAD and 12 age- and sex-matched healthy controls. Six platelet microRNAs were significantly upregulated (miR340*, miR451, miR454*, miR545:9.1. miR615-5p and miR624*) and one miRNA (miR1280) was significantly downregulated in patients with CAD as compared to healthy controls. To validate these results, we measured the expression levels of these candidate miRNAs by qRT-PCR in platelets of individuals from two independent cohorts; validation cohort I consisted of 40 patients with premature CAD and 40 healthy controls and validation cohort II consisted of 27 patients with artery disease and 40 healthy relatives. MiR340* and miR624* were confirmed to be upregulated in patients with CAD as compared to healthy controls in both validation cohorts.METHODOLOGY/PRINCIPAL FINDINGSIn this case-control study we measured relative expression levels of platelet miRNAs using microarrays from 12 patients with premature CAD and 12 age- and sex-matched healthy controls. Six platelet microRNAs were significantly upregulated (miR340*, miR451, miR454*, miR545:9.1. miR615-5p and miR624*) and one miRNA (miR1280) was significantly downregulated in patients with CAD as compared to healthy controls. To validate these results, we measured the expression levels of these candidate miRNAs by qRT-PCR in platelets of individuals from two independent cohorts; validation cohort I consisted of 40 patients with premature CAD and 40 healthy controls and validation cohort II consisted of 27 patients with artery disease and 40 healthy relatives. MiR340* and miR624* were confirmed to be upregulated in patients with CAD as compared to healthy controls in both validation cohorts.Two miRNAs in platelets are significantly upregulated in patients with CAD as compared to healthy controls. Whether the two identified miRNAs can be used as biomarkers and whether they are cause or consequence of the disease remains to be elucidated in a larger prospective study.CONCLUSION/SIGNIFICANCETwo miRNAs in platelets are significantly upregulated in patients with CAD as compared to healthy controls. Whether the two identified miRNAs can be used as biomarkers and whether they are cause or consequence of the disease remains to be elucidated in a larger prospective study.
Coronary artery disease (CAD) is the leading cause of human morbidity and mortality worldwide, underscoring the need to improve diagnostic strategies. Platelets play a major role, not only in the process of acute thrombosis during plaque rupture, but also in the formation of atherosclerosis itself. MicroRNAs are endogenous small non-coding RNAs that control gene expression and are expressed in a tissue and disease-specific manner. Therefore they have been proposed to be useful biomarkers. It remains unknown whether differences in miRNA expression levels in platelets can be found between patients with premature CAD and healthy controls. In this case-control study we measured relative expression levels of platelet miRNAs using microarrays from 12 patients with premature CAD and 12 age- and sex-matched healthy controls. Six platelet microRNAs were significantly upregulated (miR340*, miR451, miR454*, miR545:9.1. miR615-5p and miR624*) and one miRNA (miR1280) was significantly downregulated in patients with CAD as compared to healthy controls. To validate these results, we measured the expression levels of these candidate miRNAs by qRT-PCR in platelets of individuals from two independent cohorts; validation cohort I consisted of 40 patients with premature CAD and 40 healthy controls and validation cohort II consisted of 27 patients with artery disease and 40 healthy relatives. MiR340* and miR624* were confirmed to be upregulated in patients with CAD as compared to healthy controls in both validation cohorts. Two miRNAs in platelets are significantly upregulated in patients with CAD as compared to healthy controls. Whether the two identified miRNAs can be used as biomarkers and whether they are cause or consequence of the disease remains to be elucidated in a larger prospective study.
Background Coronary artery disease (CAD) is the leading cause of human morbidity and mortality worldwide, underscoring the need to improve diagnostic strategies. Platelets play a major role, not only in the process of acute thrombosis during plaque rupture, but also in the formation of atherosclerosis itself. MicroRNAs are endogenous small non-coding RNAs that control gene expression and are expressed in a tissue and disease-specific manner. Therefore they have been proposed to be useful biomarkers. It remains unknown whether differences in miRNA expression levels in platelets can be found between patients with premature CAD and healthy controls. Methodology/Principal Findings In this case-control study we measured relative expression levels of platelet miRNAs using microarrays from 12 patients with premature CAD and 12 age- and sex-matched healthy controls. Six platelet microRNAs were significantly upregulated (miR340*, miR451, miR454*, miR545:9.1. miR615-5p and miR624*) and one miRNA (miR1280) was significantly downregulated in patients with CAD as compared to healthy controls. To validate these results, we measured the expression levels of these candidate miRNAs by qRT-PCR in platelets of individuals from two independent cohorts; validation cohort I consisted of 40 patients with premature CAD and 40 healthy controls and validation cohort II consisted of 27 patients with artery disease and 40 healthy relatives. MiR340* and miR624* were confirmed to be upregulated in patients with CAD as compared to healthy controls in both validation cohorts. Conclusion/Significance Two miRNAs in platelets are significantly upregulated in patients with CAD as compared to healthy controls. Whether the two identified miRNAs can be used as biomarkers and whether they are cause or consequence of the disease remains to be elucidated in a larger prospective study.
BackgroundCoronary artery disease (CAD) is the leading cause of human morbidity and mortality worldwide, underscoring the need to improve diagnostic strategies. Platelets play a major role, not only in the process of acute thrombosis during plaque rupture, but also in the formation of atherosclerosis itself. MicroRNAs are endogenous small non-coding RNAs that control gene expression and are expressed in a tissue and disease-specific manner. Therefore they have been proposed to be useful biomarkers. It remains unknown whether differences in miRNA expression levels in platelets can be found between patients with premature CAD and healthy controls.Methodology/principal findingsIn this case-control study we measured relative expression levels of platelet miRNAs using microarrays from 12 patients with premature CAD and 12 age- and sex-matched healthy controls. Six platelet microRNAs were significantly upregulated (miR340*, miR451, miR454*, miR545:9.1. miR615-5p and miR624*) and one miRNA (miR1280) was significantly downregulated in patients with CAD as compared to healthy controls. To validate these results, we measured the expression levels of these candidate miRNAs by qRT-PCR in platelets of individuals from two independent cohorts; validation cohort I consisted of 40 patients with premature CAD and 40 healthy controls and validation cohort II consisted of 27 patients with artery disease and 40 healthy relatives. MiR340* and miR624* were confirmed to be upregulated in patients with CAD as compared to healthy controls in both validation cohorts.Conclusion/significanceTwo miRNAs in platelets are significantly upregulated in patients with CAD as compared to healthy controls. Whether the two identified miRNAs can be used as biomarkers and whether they are cause or consequence of the disease remains to be elucidated in a larger prospective study.
Audience Academic
Author Bakker, Annemieke
Pinto-Sietsma, Sara-Joan
de Ronde, Maurice W. J.
Moerland, Perry D.
Mulders, Ties A.
Creemers, Esther E.
Meijers, Joost C. M.
Trip, Mieke D.
Tijsen, Anke J.
Battjes, Suzanne
Sondermeijer, Brigitte M.
Halliani, Amalia
Marquart, Arnoud A.
Maiwald, Steffi
Kok, Maayke G. M.
Sivapalaratnam, Suthesh
AuthorAffiliation 3 Department of Experimental Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
4 Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
Leiden University Medical Center, The Netherlands
1 Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
2 Heart Failure Research Center, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
AuthorAffiliation_xml – name: 2 Heart Failure Research Center, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
– name: Leiden University Medical Center, The Netherlands
– name: 3 Department of Experimental Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
– name: 1 Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
– name: 4 Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
Author_xml – sequence: 1
  givenname: Brigitte M.
  surname: Sondermeijer
  fullname: Sondermeijer, Brigitte M.
– sequence: 2
  givenname: Annemieke
  surname: Bakker
  fullname: Bakker, Annemieke
– sequence: 3
  givenname: Amalia
  surname: Halliani
  fullname: Halliani, Amalia
– sequence: 4
  givenname: Maurice W. J.
  surname: de Ronde
  fullname: de Ronde, Maurice W. J.
– sequence: 5
  givenname: Arnoud A.
  surname: Marquart
  fullname: Marquart, Arnoud A.
– sequence: 6
  givenname: Anke J.
  surname: Tijsen
  fullname: Tijsen, Anke J.
– sequence: 7
  givenname: Ties A.
  surname: Mulders
  fullname: Mulders, Ties A.
– sequence: 8
  givenname: Maayke G. M.
  surname: Kok
  fullname: Kok, Maayke G. M.
– sequence: 9
  givenname: Suzanne
  surname: Battjes
  fullname: Battjes, Suzanne
– sequence: 10
  givenname: Steffi
  surname: Maiwald
  fullname: Maiwald, Steffi
– sequence: 11
  givenname: Suthesh
  surname: Sivapalaratnam
  fullname: Sivapalaratnam, Suthesh
– sequence: 12
  givenname: Mieke D.
  surname: Trip
  fullname: Trip, Mieke D.
– sequence: 13
  givenname: Perry D.
  surname: Moerland
  fullname: Moerland, Perry D.
– sequence: 14
  givenname: Joost C. M.
  surname: Meijers
  fullname: Meijers, Joost C. M.
– sequence: 15
  givenname: Esther E.
  surname: Creemers
  fullname: Creemers, Esther E.
– sequence: 16
  givenname: Sara-Joan
  surname: Pinto-Sietsma
  fullname: Pinto-Sietsma, Sara-Joan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/22022480$$D View this record in MEDLINE/PubMed
BookMark eNqNk11v0zAUhiM0xD7gHyCIhATiosXfcXaBVJUBlSZWDcat5ThO68qJi-3A-Pe4a4uaaUIoF7ZPnvPa59U5p9lR5zqdZc8hGENcwHcr1_tO2vE6hccAIFoS9ig7gSVGI4YAPjrYH2enIawAoJgz9iQ7RgggRDg4yVZzK6O2OobcdPlcRqO7tP9l4jKfe93K2HudT513nfS_84mPOi0fTNAy6PzidmkqE_ObtdeLPikZ1-WuyVtz_WWCCchlV28PDJGn2eNG2qCf7daz7Objxbfp59Hl1afZdHI5UgwwNqphQUnBQEMbVVJQAl4h1NCaA01Ug2BVlQUqWF3AopYUwxJKqQhVjKOSohLis-zlVndtXRA7m4KAGJQ4aXOaiNmWqJ1cibU3bapNOGnEXcD5hZA-GmW1gFrppsKy5FgSosuKM8wKCOqKFhSRJmm9393WV62uVbLPSzsQHf7pzFIs3E-RXp7KQEngzU7Aux-9DlG0Jihtrey064MoAWCYE8IT-eoe-XBxO2oh0_tN17h0rdpoiknylTNeQJKo8QNU-mrdGpVaqjEpPkh4O0hITNS3cSH7EMTs6_X_s1ffh-zrA3appY3L4Gy_aaUwBF8cGv3X4X0vJ-B8CyjvQvC6EcrEu5ZMpRkrIBCbwdmbJjaDI3aDk5LJveS9_j_T_gBGrBnn
CitedBy_id crossref_primary_10_1155_2016_2465763
crossref_primary_10_1160_TH12_08_0613
crossref_primary_10_1097_QAI_0000000000001191
crossref_primary_10_1161_CIRCRESAHA_113_300937
crossref_primary_10_1182_blood_2013_11_462432
crossref_primary_10_3390_cardiogenetics12030021
crossref_primary_10_1007_s11033_014_3426_9
crossref_primary_10_3109_09537104_2012_724483
crossref_primary_10_1373_clinchem_2017_285288
crossref_primary_10_1160_TH14_11_0947
crossref_primary_10_3892_br_2016_726
crossref_primary_10_3103_S0095452725050093
crossref_primary_10_1160_TH12_03_0211
crossref_primary_10_1016_j_lfs_2018_11_016
crossref_primary_10_1373_clinchem_2013_204917
crossref_primary_10_3390_diagnostics10110875
crossref_primary_10_1016_j_atherosclerosis_2015_06_037
crossref_primary_10_1155_2015_682857
crossref_primary_10_1371_journal_pone_0080738
crossref_primary_10_3390_biomedicines11102864
crossref_primary_10_3892_mmr_2016_4936
crossref_primary_10_1016_j_gene_2016_08_028
crossref_primary_10_3389_fgene_2022_936937
crossref_primary_10_1111_apha_13353
crossref_primary_10_1111_jth_12214
crossref_primary_10_3390_ijms22042102
crossref_primary_10_1038_emm_2014_81
crossref_primary_10_1160_TH12_08_0550
crossref_primary_10_1002_jcp_26324
crossref_primary_10_3390_ijms22094937
crossref_primary_10_1038_s41598_024_76243_x
crossref_primary_10_3389_fcvm_2022_879351
crossref_primary_10_1016_j_mehy_2012_09_020
crossref_primary_10_1161_ATVBAHA_114_305176
crossref_primary_10_1089_ars_2017_7289
crossref_primary_10_1186_s12933_024_02374_0
crossref_primary_10_1016_j_ijcard_2015_10_098
crossref_primary_10_3389_fgene_2021_793523
crossref_primary_10_5482_HAMO_13_01_0002
crossref_primary_10_1371_journal_pone_0246083
crossref_primary_10_3390_ijms24010616
crossref_primary_10_1002_jcb_27476
crossref_primary_10_1515_med_2020_0001
crossref_primary_10_1182_blood_2011_12_396440
crossref_primary_10_3390_biom14121554
crossref_primary_10_1007_s12265_015_9640_6
crossref_primary_10_1016_j_mam_2012_08_001
crossref_primary_10_1161_CIRCRESAHA_115_308237
crossref_primary_10_1177_2516865720988567
crossref_primary_10_1160_TH12_03_0153
crossref_primary_10_1155_2014_985408
crossref_primary_10_1016_j_ijcard_2014_02_008
crossref_primary_10_1160_TH16_07_0503
crossref_primary_10_2217_bmm_13_8
crossref_primary_10_1007_s11515_014_1340_0
crossref_primary_10_1096_fj_15_271312
crossref_primary_10_1155_2016_2872507
crossref_primary_10_1186_s12872_021_02211_2
crossref_primary_10_1007_s00109_015_1315_x
ContentType Journal Article
Copyright COPYRIGHT 2011 Public Library of Science
2011 Sondermeijer et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Sondermeijer et al. 2011
Copyright_xml – notice: COPYRIGHT 2011 Public Library of Science
– notice: 2011 Sondermeijer et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: Sondermeijer et al. 2011
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
IOV
ISR
3V.
7QG
7QL
7QO
7RV
7SN
7SS
7T5
7TG
7TM
7U9
7X2
7X7
7XB
88E
8AO
8C1
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
ABJCF
ABUWG
AEUYN
AFKRA
ARAPS
ATCPS
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
C1K
CCPQU
D1I
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
KB.
KB0
KL.
L6V
LK8
M0K
M0S
M1P
M7N
M7P
M7S
NAPCQ
P5Z
P62
P64
PATMY
PDBOC
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PTHSS
PYCSY
RC3
7X8
5PM
DOA
DOI 10.1371/journal.pone.0025946
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: Opposing Viewpoints
In Context: Science
ProQuest Central (Corporate)
Animal Behavior Abstracts
Bacteriology Abstracts (Microbiology B)
Biotechnology Research Abstracts
Nursing & Allied Health Database
Ecology Abstracts
Entomology Abstracts (Full archive)
Immunology Abstracts
Meteorological & Geoastrophysical Abstracts
Nucleic Acids Abstracts
Virology and AIDS Abstracts
Agricultural Science Collection
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Collection
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Materials Science & Engineering Collection
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
Advanced Technologies & Computer Science Collection
Agricultural & Environmental Science Collection
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Technology Collection
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One
ProQuest Materials Science Collection
ProQuest Central Korea
Engineering Research Database
Proquest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Materials Science Database
Nursing & Allied Health Database (Alumni Edition)
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest Engineering Collection
ProQuest Biological Science Collection
Agriculture Science Database
ProQuest Health & Medical Collection
Medical Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Engineering Database
Nursing & Allied Health Premium
Advanced Technologies & Aerospace Database
ProQuest Advanced Technologies & Aerospace Collection
Biotechnology and BioEngineering Abstracts
Environmental Science Database
Materials Science Collection
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
Engineering Collection
Environmental Science Collection
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Agricultural Science Database
Publicly Available Content Database
ProQuest Central Student
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Meteorological & Geoastrophysical Abstracts
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Engineering Collection
Advanced Technologies & Aerospace Collection
Engineering Database
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Agricultural Science Collection
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Ecology Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Environmental Science Collection
Entomology Abstracts
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Environmental Science Database
ProQuest Nursing & Allied Health Source (Alumni)
Engineering Research Database
ProQuest One Academic
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest One Academic (New)
Technology Collection
Technology Research Database
ProQuest One Academic Middle East (New)
Materials Science Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
ProQuest Health & Medical Research Collection
Genetics Abstracts
ProQuest Engineering Collection
Biotechnology Research Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Agricultural & Environmental Science Collection
AIDS and Cancer Research Abstracts
Materials Science Database
ProQuest Materials Science Collection
ProQuest Public Health
ProQuest Nursing & Allied Health Source
ProQuest SciTech Collection
Advanced Technologies & Aerospace Database
ProQuest Medical Library
Animal Behavior Abstracts
Materials Science & Engineering Collection
Immunology Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
Agricultural Science Database
MEDLINE - Academic

MEDLINE





Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: PIMPY
  name: Publicly Available Content Database
  url: http://search.proquest.com/publiccontent
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Sciences (General)
Medicine
Biology
DocumentTitleAlternate Platelet miRNAs in Coronary Artery Disease
EISSN 1932-6203
ExternalDocumentID 1309317585
oai_doaj_org_article_1ecefb3a983a44e9b8636710db57524f
PMC3192762
2900229211
A476868714
22022480
10_1371_journal_pone_0025946
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Netherlands
GeographicLocations_xml – name: Netherlands
GroupedDBID ---
123
29O
2WC
53G
5VS
7RV
7X2
7X7
7XC
88E
8AO
8C1
8CJ
8FE
8FG
8FH
8FI
8FJ
A8Z
AAFWJ
AAUCC
AAWOE
AAYXX
ABDBF
ABIVO
ABJCF
ABUWG
ACCTH
ACGFO
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
ADRAZ
AEAQA
AENEX
AEUYN
AFFHD
AFKRA
AFPKN
AFRAH
AHMBA
ALMA_UNASSIGNED_HOLDINGS
AOIJS
APEBS
ARAPS
ATCPS
BAWUL
BBNVY
BCNDV
BENPR
BGLVJ
BHPHI
BKEYQ
BPHCQ
BVXVI
BWKFM
CCPQU
CITATION
CS3
D1I
D1J
D1K
DIK
DU5
E3Z
EAP
EAS
EBD
EMOBN
ESX
EX3
F5P
FPL
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
IAO
IEA
IGS
IHR
IHW
INH
INR
IOV
IPNFZ
IPY
ISE
ISR
ITC
K6-
KB.
KQ8
L6V
LK5
LK8
M0K
M1P
M48
M7P
M7R
M7S
M~E
NAPCQ
O5R
O5S
OK1
OVT
P2P
P62
PATMY
PDBOC
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQGLB
PQQKQ
PROAC
PSQYO
PTHSS
PYCSY
RIG
RNS
RPM
SV3
TR2
UKHRP
WOQ
WOW
~02
~KM
ALIPV
CGR
CUY
CVF
ECM
EIF
NPM
PV9
RZL
BBORY
3V.
7QG
7QL
7QO
7SN
7SS
7T5
7TG
7TM
7U9
7XB
8FD
8FK
AZQEC
C1K
DWQXO
FR3
GNUQQ
H94
K9.
KL.
M7N
P64
PKEHL
PQEST
PQUKI
PRINS
RC3
7X8
ESTFP
PUEGO
5PM
-
02
AAPBV
ABPTK
ADACO
BBAFP
KM
ID FETCH-LOGICAL-c6066-d1754760f5fc950908b22f5d80e4cf21bb97276d717da53191aac45c682952913
IEDL.DBID DOA
ISSN 1932-6203
IngestDate Fri Nov 26 17:11:46 EST 2021
Mon Nov 10 04:33:01 EST 2025
Tue Nov 04 02:01:08 EST 2025
Mon Sep 08 14:52:06 EDT 2025
Sat Nov 29 14:54:04 EST 2025
Sat Nov 29 13:12:20 EST 2025
Sat Nov 29 09:52:23 EST 2025
Wed Nov 26 09:23:25 EST 2025
Wed Nov 26 09:26:20 EST 2025
Thu May 22 21:19:53 EDT 2025
Mon Jul 21 05:57:01 EDT 2025
Sat Nov 29 02:24:16 EST 2025
Tue Nov 18 20:54:36 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 10
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
Creative Commons Attribution License
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c6066-d1754760f5fc950908b22f5d80e4cf21bb97276d717da53191aac45c682952913
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Conceived and designed the experiments: JCMM EEC SJPS. Performed the experiments: BMS AB AH MWJdR AAM AJT TAM MGMK SB SM SS MDT. Analyzed the data: BMS AB PDM. Contributed reagents/materials/analysis tools: AH AAM AJT EEC. Wrote the paper: BMS AB SJPS. Acquisition of Data: BMS AB AH MWJdR TAM MGMK SB SS MDT. Final approval of the version to be published: BMS AB AH MWJdR AAM AJT TAM MGMK SB SM SS MDT PDM JCMM EEC SJPS.
OpenAccessLink https://doaj.org/article/1ecefb3a983a44e9b8636710db57524f
PMID 22022480
PQID 1309317585
PQPubID 1436336
PageCount e25946
ParticipantIDs plos_journals_1309317585
doaj_primary_oai_doaj_org_article_1ecefb3a983a44e9b8636710db57524f
pubmedcentral_primary_oai_pubmedcentral_nih_gov_3192762
proquest_miscellaneous_900638448
proquest_journals_1309317585
gale_infotracmisc_A476868714
gale_infotracacademiconefile_A476868714
gale_incontextgauss_ISR_A476868714
gale_incontextgauss_IOV_A476868714
gale_healthsolutions_A476868714
pubmed_primary_22022480
crossref_citationtrail_10_1371_journal_pone_0025946
crossref_primary_10_1371_journal_pone_0025946
PublicationCentury 2000
PublicationDate 2011-10-13
PublicationDateYYYYMMDD 2011-10-13
PublicationDate_xml – month: 10
  year: 2011
  text: 2011-10-13
  day: 13
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: San Francisco
– name: San Francisco, USA
PublicationTitle PloS one
PublicationTitleAlternate PLoS One
PublicationYear 2011
Publisher Public Library of Science
Public Library of Science (PLoS)
Publisher_xml – name: Public Library of Science
– name: Public Library of Science (PLoS)
References 21785714 - Cardiol Res Pract. 2011;2011:532915
15992651 - J Am Coll Cardiol. 2005 Jul 5;46(1):158-65
20159880 - Eur Heart J. 2010 Mar;31(6):659-66
18773077 - PLoS One. 2008;3(9):e3148
20886220 - Basic Res Cardiol. 2011 Jan;106(1):13-23
14657504 - Science. 2004 Jan 2;303(5654):83-6
18508790 - Haematologica. 2008 Jul;93(7):1009-16
18573170 - Eur J Haematol. 2008 Oct;81(4):304-10
19668211 - Nat Struct Mol Biol. 2009 Sep;16(9):961-6
15965474 - Nat Genet. 2005 Jul;37(7):766-70
20413612 - Genes Dev. 2010 May 15;24(10):992-1009
20029200 - Cardiology. 2010;115(3):163-9
21411089 - Atherosclerosis. 2011 Jun;216(2):452-7
18077812 - N Engl J Med. 2007 Dec 13;357(24):2482-94
20395621 - Clin Chem. 2010 Jul;56(7):1183-5
19002258 - PLoS One. 2008;3(11):e3694
20595655 - Circ Res. 2010 Sep 3;107(5):677-84
11591627 - Circulation. 2001 Oct 9;104(15):1863-7
18663219 - Proc Natl Acad Sci U S A. 2008 Jul 29;105(30):10513-8
17060945 - Nat Rev Cancer. 2006 Nov;6(11):857-66
17786230 - J Clin Invest. 2007 Sep;117(9):2369-76
20921333 - Circ Cardiovasc Genet. 2010 Dec;3(6):499-506
15944708 - Nature. 2005 Jun 9;435(7043):834-8
21796641 - Biopharm Drug Dispos. 2011 Sep;32(6):355-67
20218970 - Clin Sci (Lond). 2010 Jul;119(2):87-95
12928466 - JAMA. 2003 Aug 20;290(7):898-904
16111679 - FEBS Lett. 2005 Oct 31;579(26):5911-22
20065196 - Arch Intern Med. 2010 Jan 11;170(1):27-40
18303086 - Physiol Genomics. 2008 Apr 22;33(2):139-47
18713256 - Clin Genet. 2008 Oct;74(4):296-306
11574787 - Curr Opin Cardiol. 2001 Jul;16(4):251-60
19896465 - Biochem Biophys Res Commun. 2010 Jan 1;391(1):73-7
20185794 - Circ Res. 2010 Apr 2;106(6):1035-9
18523662 - PLoS One. 2008;3(6):e2360
19696117 - Clin Chem. 2009 Nov;55(11):1944-9
12928465 - JAMA. 2003 Aug 20;290(7):891-7
References_xml – reference: 15992651 - J Am Coll Cardiol. 2005 Jul 5;46(1):158-65
– reference: 12928466 - JAMA. 2003 Aug 20;290(7):898-904
– reference: 18573170 - Eur J Haematol. 2008 Oct;81(4):304-10
– reference: 21785714 - Cardiol Res Pract. 2011;2011:532915
– reference: 16111679 - FEBS Lett. 2005 Oct 31;579(26):5911-22
– reference: 17786230 - J Clin Invest. 2007 Sep;117(9):2369-76
– reference: 20218970 - Clin Sci (Lond). 2010 Jul;119(2):87-95
– reference: 11591627 - Circulation. 2001 Oct 9;104(15):1863-7
– reference: 15965474 - Nat Genet. 2005 Jul;37(7):766-70
– reference: 20029200 - Cardiology. 2010;115(3):163-9
– reference: 21796641 - Biopharm Drug Dispos. 2011 Sep;32(6):355-67
– reference: 12928465 - JAMA. 2003 Aug 20;290(7):891-7
– reference: 20886220 - Basic Res Cardiol. 2011 Jan;106(1):13-23
– reference: 11574787 - Curr Opin Cardiol. 2001 Jul;16(4):251-60
– reference: 20921333 - Circ Cardiovasc Genet. 2010 Dec;3(6):499-506
– reference: 17060945 - Nat Rev Cancer. 2006 Nov;6(11):857-66
– reference: 18713256 - Clin Genet. 2008 Oct;74(4):296-306
– reference: 18523662 - PLoS One. 2008;3(6):e2360
– reference: 18663219 - Proc Natl Acad Sci U S A. 2008 Jul 29;105(30):10513-8
– reference: 18077812 - N Engl J Med. 2007 Dec 13;357(24):2482-94
– reference: 18773077 - PLoS One. 2008;3(9):e3148
– reference: 15944708 - Nature. 2005 Jun 9;435(7043):834-8
– reference: 18303086 - Physiol Genomics. 2008 Apr 22;33(2):139-47
– reference: 19896465 - Biochem Biophys Res Commun. 2010 Jan 1;391(1):73-7
– reference: 20413612 - Genes Dev. 2010 May 15;24(10):992-1009
– reference: 19002258 - PLoS One. 2008;3(11):e3694
– reference: 21411089 - Atherosclerosis. 2011 Jun;216(2):452-7
– reference: 19668211 - Nat Struct Mol Biol. 2009 Sep;16(9):961-6
– reference: 19696117 - Clin Chem. 2009 Nov;55(11):1944-9
– reference: 18508790 - Haematologica. 2008 Jul;93(7):1009-16
– reference: 20395621 - Clin Chem. 2010 Jul;56(7):1183-5
– reference: 20185794 - Circ Res. 2010 Apr 2;106(6):1035-9
– reference: 20595655 - Circ Res. 2010 Sep 3;107(5):677-84
– reference: 20159880 - Eur Heart J. 2010 Mar;31(6):659-66
– reference: 14657504 - Science. 2004 Jan 2;303(5654):83-6
– reference: 20065196 - Arch Intern Med. 2010 Jan 11;170(1):27-40
SSID ssj0053866
Score 2.3622208
Snippet Coronary artery disease (CAD) is the leading cause of human morbidity and mortality worldwide, underscoring the need to improve diagnostic strategies....
Background Coronary artery disease (CAD) is the leading cause of human morbidity and mortality worldwide, underscoring the need to improve diagnostic...
BackgroundCoronary artery disease (CAD) is the leading cause of human morbidity and mortality worldwide, underscoring the need to improve diagnostic...
Background Coronary artery disease (CAD) is the leading cause of human morbidity and mortality worldwide, underscoring the need to improve diagnostic...
SourceID plos
doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage e25946
SubjectTerms Adult
Arteriosclerosis
Atherosclerosis
Bioinformatics
Biology
Biomarkers
Blood platelets
Blood Platelets - metabolism
Cardiac patients
Cardiology
Cardiovascular disease
Care and treatment
Case-Control Studies
Cohort Studies
Coronary artery
Coronary artery disease
Coronary Artery Disease - genetics
Coronary heart disease
Coronary vessels
Data collection
Diagnostic systems
Disease control
Disease prevention
DNA microarrays
Epidemiology
Family medical history
Gene expression
Gene Expression Profiling
Genetic Association Studies
Health aspects
Heart attacks
Heart diseases
Heart failure
Humans
Male
Medical research
Medicine
MicroRNA
MicroRNAs
MicroRNAs - genetics
MicroRNAs - metabolism
Middle Aged
miRNA
Morbidity
Mortality
Patients
Platelets
Reproducibility of Results
Ribonucleic acid
Risk assessment
RNA
Teaching hospitals
Thromboembolism
Thrombosis
Up-Regulation - genetics
SummonAdditionalLinks – databaseName: Nursing & Allied Health Database
  dbid: 7RV
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bb9MwFLagIMQLsHFZYYCFkICHbLk4TvyEytgEEpSqsGlvkeNL6dQlJWmR-Peck7hhQRMg8RQ1Ponqc8vn23cIeQ6QNdecSU8Y6XssypknTSI8I6MgiKSfqLg5KPwhGY_T01MxcRNutdtWucmJTaLWpcI58v0Al-wCRLevl988rBqFq6uuhMZVci1AbAz-nExPNpkYYplzd1wuSoJ9Z529ZVkYnEiJBcLeC5-jhrW_y82D5aKsLwOev--fvPBBOrr9v125Q245KEpHre9skSum2CY3PrrF9m2y5eK-pi8dOfWru-RssgB0Csau6bygk5aVtaY4nUsnFRLAritDD5AXQVY_8OUGLm_bZSB6iOW45yt6vKzMzBUOo6Wl5_PpeBQxn8pCtz94yO6R46PDLwfvPFevwVM4DPI09Ikl3LexVQKAiJ_mYWhjnfqGKRsGeS4ALXENI0gtMfYDKRWLFU9DEYciiO6TQQG22SGUGcmtSaz2NYMBZJ7HgmsuLQAW0J7xhyTamC1Tjswca2ossmaFLoFBTavEDI2dOWMPidc9tWzJPP4i_wY9opNFKu7mRlnNMhfZWWCUsXkkRRpJxozIUx5xwG06ByQcMjskT9GfsvZca5dQshGoKuUwXmVD8qyRQDqOAvf7zOS6rrP3n07-QejztCf0wgnZEtShpDtjAX1Cmq-e5G5PEpKK6jXvoPdvtFJnv3wWntx49eXNtGvGl-IevsKU6zoTDTwGaw7JgzZ-OsWGIULJFMya9CKrp_l-SzH_2pChgxuBT4UP__yvHpGbodu8GUS7ZLCq1uYxua6-r-Z19aTJGj8BlJx1ig
  priority: 102
  providerName: ProQuest
– databaseName: Public Library of Science (PLoS) Journals Open Access
  dbid: FPL
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwELegIMQLsPGxwgALIQEPgcR2nPixjFUgjVINhvYWOY4NQSWtkhaJ_567xA1k2gQ8RY3PUXof9u9y9s-EPAXImhdS6EBZHQaC5yLQNlGB1TyKuA4TE7cbhY-S2Sw9PVXz34nimQo-T6JXXqcvV8vK4uePWAl5mVxhXEpMtqbzo-3IC7Erpd8ed1HPwfTTsvT3Y_FotVg25wHNs-sl_5iApjf_99VvkRseatJJ5xs75JKtdsm1976Yvkt2fFw39Lknn35xm3ybLwB9gjEbWlZ03rGuNhQ_19J5jQSvm9rSA-Q90PVPfLiFy5uuzEMP8bjtck1PVnV3xj1YnS4d_V4ezyZchFRXRfdDMnGHnEwPPx28Dfx5DIHBNCcoAGqIRIYudkYB0AjTnDEXF2lohXEsynMFaEgWkCEWGmM70tqI2MiUqZipiN8lowpUsUeosFo6m7giLAQkiHkeK1lI7QCQwKRqwzHhWzNlxpOV45kZi6ytwCWQtHRKzFC3mdftmAR9r1VH1vEX-dfoAb0sUm23N8CImY_cLLLGupxrlXIthFV5KrkEXFbkgHSZcGPyGP0n6_at9gNGNgFVpRLyUTEmT1oJpNuocD3PF71pmuzdh8__IPTxeCD0zAu5JajDaL-HAv4T0ngNJPcHkjBomEHzHnr7VisNVjUVQsk0hp7bCDi_mfbN-FBco1fZ5abJVAt_wZpjcq-Ll16xjCFUTMGsySCSBpoftlTl15bsHNwIfIrdv_iFH5DrzC_MjPg-Ga3rjX1Irpof67KpH7UjxC9mI2O9
  priority: 102
  providerName: Public Library of Science
Title Platelets in Patients with Premature Coronary Artery Disease Exhibit Upregulation of miRNA340 and miRNA624
URI https://www.ncbi.nlm.nih.gov/pubmed/22022480
https://www.proquest.com/docview/1309317585
https://www.proquest.com/docview/900638448
https://pubmed.ncbi.nlm.nih.gov/PMC3192762
https://doaj.org/article/1ecefb3a983a44e9b8636710db57524f
http://dx.doi.org/10.1371/journal.pone.0025946
Volume 6
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: DOA
  dateStart: 20060101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: M~E
  dateStart: 20060101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVPQU
  databaseName: Advanced Technologies & Aerospace Database
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: P5Z
  dateStart: 20061201
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/hightechjournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Agricultural Science Database
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: M0K
  dateStart: 20061201
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/agriculturejournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Biological Science Database
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: M7P
  dateStart: 20061201
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/biologicalscijournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Engineering Database
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: M7S
  dateStart: 20061201
  isFulltext: true
  titleUrlDefault: http://search.proquest.com
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Environmental Science Database
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: PATMY
  dateStart: 20061201
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/environmentalscience
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: 7X7
  dateStart: 20061201
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Materials Science Database
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: KB.
  dateStart: 20061201
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/materialsscijournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Nursing & Allied Health Database
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: 7RV
  dateStart: 20061201
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/nahs
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: BENPR
  dateStart: 20061201
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Public Health Database
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: 8C1
  dateStart: 20061201
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/publichealth
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Publicly Available Content Database
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: PIMPY
  dateStart: 20061201
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
– providerCode: PRVATS
  databaseName: Public Library of Science (PLoS) Journals Open Access
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: FPL
  dateStart: 20060101
  isFulltext: true
  titleUrlDefault: http://www.plos.org/publications/
  providerName: Public Library of Science
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwELeg8MDLxPhaxygWQgIesuXDsePHdlrFtK1EHUyFl8hxnFHUpVXTIu2_5y5xowZNGg-8nNT6XKV3Z_t38flnQt4DZE0zzpQjjXIdFqTMUUZIx6jA8wLlCh1WB4XPxWgUTSYy3rrqC2vCanrg2nBHntEmTwMlo0AxZmQa8YDDspilADR8luPs6wq5SabqORhGMef2oFwgvCPrl8PFvDD4CiWUCHi3FqKKr7-ZlTuL2by8C3L-XTm5tRQNn5IdiyFpv372XfLAFM_Irh2lJf1oqaQ_PSe_4hlgSXBNSacFtRyqJcWXr3SxRLrW9dJQjSwGanlLq_rOW2o3bajBy7OnK7oG1Wt7zRed5_RmOh71A-ZSVWT1B-6zF-Tb8OTr8WfH3q7gaExanAyAAxPczcNcS4ANbpT6fh5mkWuYzn0vTSVgG55BvpcpHKmeUpqFmke-DH3pBS9JpwB77hHKjOK5EXnmZgzSvTQNJc-4ygFewBJp3C4JNqZOtKUexxswZkm1nyYgBaktl6CDEuugLnGaXouaeuMe_QF6sdFF4uzqCwinxIZTcl84dclbjIGkPoXaDP-kD6aKOGSXrEveVRpInlFgdc61Wpdlcvrl6h-ULsctpQ9WKZ-DObSyJyLgPyEpV0vzoKUJU4BuNe9hxG6sUuIepURgGIXQcxPFdzfTphl_FCvuCjNfl4mswCx4s0te1THfGNb3EfhF4FbRGg0ty7dbiunPirocwghiyt__H656TZ74tiDTCw5IZ7Vcmzfksf69mpbLHnkoxlcoJ6KSEcjo2OuRR4OTUTzuVfMFyGF8DvJscAjywj1DKeJKXoKMwx_QIz69iL__AWCUccM
linkProvider Directory of Open Access Journals
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3db9MwELdGQcALsPGxwmAWAgEPYYnjOMkDQmUf2rSuVGNDEy_BcZxSVJKStKD9U_yN3CVOWdAEvOyBp6r1xWrOvzv_bJ_vCHkClDVOBJdWqKVtcTfmltR-aGnpOo4rbV951UXhvj8YBCcn4XCJ_GjuwmBYZeMTK0ed5Ar3yDccPLJzkN2-nn61sGoUnq42JTRqWOzr0--wZCtf7W3B-D5lbGf7aHPXMlUFLIVk3UqgE-4LO_VSFcJ0aQcxY6mXBLbmKmVOHIcwp4sE1jmJRIQ6UiruKRGw0GOh40K_l8hlzpmNVjT0PjSeH3yHEOZ6nus7GwYNL6d5pnHjxguRZp-Z_qoqAYu5oDOd5OV5RPf3eM0zE-DOzf9NdbfIDUO1aa-2jWWypLMVcvXABBOskGXj10r63CTffnGbfB5OgH0DmEs6zuiwzjpbUtyupsMCE9zOC003Me-DLE6xcw0fW_UxF93GcuPjGT2eFnpkCqPRPKVfxoeDnsttKrOk_iIYv0OOL-T175JOBlhYJZRrKVLtp4mdcFggx7EXikTIFAgZjJa2u8RtYBIpk6wda4ZMouoE0odFW63ECMEVGXB1ibV4alonK_mL_BtE4EIWU41XP-TFKDKeK3K00mnsyjBwJec6jAPhCuClSQxMn_G0S9YRv1F9b3fhMKMeqCoQsB7nXfK4ksB0IxnGM43kvCyjvbfv_0Ho3WFL6JkRSnNQh5LmDgm8E6Yxa0mutSTBaapW8ypaW6OVMvplI_BkY0XnN9NFM3aKMYqZzudlFFb0H0azS-7V9rpQLGNIlQMYVr9lyS3Nt1uy8acq2TvACDDF7v_5X62Ta7tHB_2ovzfYf0CuMxOo6rhrpDMr5vohuaK-zcZl8ajyWJR8vGg7_wlhqc63
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3db9MwELdGQRMvwMbHCoNZCAQ8hCaO4yQPCJV1FdVGqcaGJl6CkzilqCQlaUH71_jruEucsKAJeNkDT1Xri9Wcf_dln-8IeQQuaxgLLg1fSdPgdsgNqVzfUNK2LFuabuSUF4UP3PHYOznxJ2vkR30XBtMqa51YKuo4i3CPvGfhkZ2F3m0v0WkRk8Hw5eKrgR2k8KS1bqdRQWRfnX6H8K14MRrAWj9mbLh3tPva0B0GjAgddyOGCbkrzMRJIh9Mp-mFjCVO7JmKRwmzwtAH-y5iiHliiWi1pIy4EwmP-Q7zLRvmvUQuuxBjYjrhxPlQWwHQI0Loq3q2a_U0Mp4vslThJo7jo8t9xhSWHQMau9BZzLPiPKf399zNM8ZweP1_ZuMNck274LRfycwGWVPpJll_o5MMNsmG1ncFfaqLcj-7ST5P5uCVA8gLOkvppKpGW1DcxqaTHAvfrnJFd7EehMxPcXIFH4Pq-IvuYRvy2ZIeL3I11Q3TaJbQL7PDcd_mJpVpXH0RjN8ixxfy-rdJJwVcbBHKlRSJcpPYjDkEzmHo-CIWMgFHDVZOmV1i15AJIl3EHXuJzIPyZNKFYK5iYoBACzTQusRonlpURUz-Qv8K0djQYgny8ocsnwZaowWWilQS2tL3bMm58kNP2AL81TiECIDxpEt2EMtBdZ-3UaRBH1jlCYjTeZc8LCmwDEmKSJzKVVEEo7fv_4Ho3WGL6IkmSjJgRyT13RJ4Jyxv1qLcblGCMo1aw1soeTVXiuCXvMCTtUSdP0ybYZwUcxdTla2KwC_DAljNLrlTyW7DWMbQhfZgWd2WVLc43x5JZ5_KIvAAI8AUu_vnf7VD1kG8g4PReP8eucp0_qplb5POMl-p--RK9G05K_IHpfKi5ONFi_lPuJLXgQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Platelets+in+Patients+with+Premature+Coronary+Artery+Disease+Exhibit+Upregulation+of+miRNA340+and+miRNA624&rft.jtitle=PloS+one&rft.au=Sivapalaratnam%2C+Suthesh&rft.au=Maiwald%2C+Steffi&rft.au=Pinto-Sietsma%2C+Sara-Joan&rft.au=Kok%2C+Maayke+G.+M&rft.date=2011-10-13&rft.pub=Public+Library+of+Science&rft.issn=1932-6203&rft.eissn=1932-6203&rft.volume=6&rft.issue=10&rft.spage=e25946&rft_id=info:doi/10.1371%2Fjournal.pone.0025946&rft.externalDBID=n%2Fa&rft.externalDocID=A476868714
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon